Stacey Clardy MD PhD
Neuroimmunology/Multiple Sclerosis
Autoimmune Neurologist
Join to view full profile
50 N Medical DrSalt Lake City, UT 84132
Phone+1 801-585-6387
Dr. Clardy is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stacey L. Clardy MD PhD is a neurologist in Salt Lake City, UT and is affiliated with multiple hospitals in the area, including University of Utah Health, Veterans Affairs Salt Lake City Health Care System, and Primary Children's Hospital. She received her medical degree and PhD from Penn State College of Medicine, and completed fellowship at the Mayo Clinic in Rochester, MN. She has been in practice 7 years. She specializes in Autoimmune Neurology.
Education & Training
Mayo Clinic College of Medicine and ScienceFellowship, Autoimmune Neurology, 2012 - 2013
Penn State Milton S Hershey Medical CenterResidency, Neurology, 2008 - 2012- Penn State Milton S Hershey Medical CenterInternship, Internal Medicine, 2007 - 2008
Pennsylvania State University College of MedicineClass of 2007
Certifications & Licensure
UT State Medical License 2013 - 2028
MT State Medical License 2020 - 2026
CO State Medical License 2020 - 2023
ID State Medical License 2020 - 2023
NV State Medical License 2020 - 2023
WY State Medical License 2020 - 2023
MN State Medical License 2012 - 2014
American Board of Psychiatry and Neurology Neurology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
Clinical Trials
- The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis Start of enrollment: 2022 Mar 30
Publications & Presentations
PubMed
- National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care, 2013-2023.Ka-Ho Wong, Marissa Castillo, Jordan King, Erin Bouldin, John W Rose
Neurology. 2026-09-22 - Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.Andreu Vilaseca, Philippe A Bilodeau, Georgios Gakis, Andrea Savransky, Joao Mahler Ferreira Oliveira
JAMA Neurology. 2026-07-13 - Anti-N-methyl-d-aspartate receptor encephalitis: insights and future treatment directions.Yoji Hoshina, Tammy L Smith, Melissa A Wright, Gregory S Day, Maarten J Titulaer
Trends in Molecular Medicine. 2026-05-01
Press Mentions
Monogenic Mimics of Neuroinflammatory Phenotypes in Children and Young Adults - Part 1January 8th, 2026- December 2025 Recall: Topics on Neuropalliative CareDecember 1st, 2025
- Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple SclerosisNovember 6th, 2025
Grant Support
- The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (ExTINGUISH)National Institutes of Health/NINDS2021–2026
Professional Memberships
- American Neurological AssociationMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
